Brief: Idera Pharmaceuticals Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate Update

Aceragen

31/03/2022 22:03

March 31 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * Q4 LOSS PER SHARE $0.08
    * CASH POSITION AS OF DECEMBER 31, 2021 WAS $32.5 MILLION
    * IDERA - SEES CURRENT CASH POSITION TO FUND OPERATIONS
THROUGH
ONE-YEAR PERIOD SUBSEQUENT TO MARCH 31, 2022 FILING DATE OF
ANNUAL REPORT FORM 10-K

Source text for Eikon:  ID:nGNX18WdW1 
Further company coverage:  IDRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))